Search

everythinglearnresearchcommunity

for

Search:↓

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Antera 3D® offers more precise and detailed scar assessment than traditional methods.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

Oral ulcers are common in SLE patients and often link to other symptoms.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

The ABHRS has outlined its goals for the next year.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Razor bumps are linked to a genetic variant, misoprostol helps erythromelalgia pain, steroid ointments don't affect skin rhythms, and certain antibodies are common in localized scleroderma.